353 related articles for article (PubMed ID: 34609508)
1. Cardiovascular consequences of viral infections: from COVID to other viral diseases.
Schultheiss HP; Baumeier C; Pietsch H; Bock CT; Poller W; Escher F
Cardiovasc Res; 2021 Nov; 117(13):2610-2623. PubMed ID: 34609508
[TBL] [Abstract][Full Text] [Related]
2. Serological and Molecular Biological Studies of Parvovirus B19, Coxsackie B Viruses, and Adenoviruses as Potential Cardiotropic Viruses in Bulgaria.
Ivanova SK; Angelova SG; Stoyanova AP; Georgieva IL; Nikolaeva-Glomb LK; Mihneva ZG; Korsun NS
Folia Med (Plovdiv); 2016 Dec; 58(4):250-256. PubMed ID: 28068282
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens.
Pankuweit S; Moll R; Baandrup U; Portig I; Hufnagel G; Maisch B
Hum Pathol; 2003 May; 34(5):497-503. PubMed ID: 12792925
[TBL] [Abstract][Full Text] [Related]
4. Fatal parvovirus B19 myocarditis in children and possible dysimmune mechanism.
Koehl B; Oualha M; Lesage F; Rambaud C; Canioni D; Hubert P; Leruez-Ville M
Pediatr Infect Dis J; 2012 Apr; 31(4):418-21. PubMed ID: 22173134
[TBL] [Abstract][Full Text] [Related]
5. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.
Tschöpe C; Ammirati E; Bozkurt B; Caforio ALP; Cooper LT; Felix SB; Hare JM; Heidecker B; Heymans S; Hübner N; Kelle S; Klingel K; Maatz H; Parwani AS; Spillmann F; Starling RC; Tsutsui H; Seferovic P; Van Linthout S
Nat Rev Cardiol; 2021 Mar; 18(3):169-193. PubMed ID: 33046850
[TBL] [Abstract][Full Text] [Related]
6. Human parvovirus B19-associated myocarditis.
Bock CT; Klingel K; Kandolf R
N Engl J Med; 2010 Apr; 362(13):1248-9. PubMed ID: 20357294
[No Abstract] [Full Text] [Related]
7. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
Escher F; Modrow S; Sabi T; Kühl U; Lassner D; Schultheiss HP; Noutsias M
Med Sci Monit; 2008 Dec; 14(12):CR589-97. PubMed ID: 19043365
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19.
Pankuweit S; Ruppert V; Eckhardt H; Strache D; Maisch B
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):344-7. PubMed ID: 16316398
[TBL] [Abstract][Full Text] [Related]
9. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature.
Verdonschot J; Hazebroek M; Merken J; Debing Y; Dennert R; Brunner-La Rocca HP; Heymans S
Eur J Heart Fail; 2016 Dec; 18(12):1430-1441. PubMed ID: 27748022
[TBL] [Abstract][Full Text] [Related]
10. Viral myocarditis in combination with genetic cardiomyopathy as a cause of sudden death. An autopsy series.
Callon D; Joanne P; Andreoletti L; Agbulut O; Chevalier P; Fornès P
BMC Cardiovasc Disord; 2024 May; 24(1):282. PubMed ID: 38811883
[TBL] [Abstract][Full Text] [Related]
11. [Virus etiology of inflammatory cardiomyopathy].
Kandolf R
Dtsch Med Wochenschr; 2004 Oct; 129(41):2187-92. PubMed ID: 15457399
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review of PCR Proof of Parvovirus B19 Genomes in Endomyocardial Biopsies of Patients Presenting with Myocarditis or Dilated Cardiomyopathy.
Rigopoulos AG; Klutt B; Matiakis M; Apostolou A; Mavrogeni S; Noutsias M
Viruses; 2019 Jun; 11(6):. PubMed ID: 31216741
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topic.
Shaboodien G; Maske C; Wainwright H; Smuts H; Ntsekhe M; Commerford PJ; Badri M; Mayosi BM
Cardiovasc J Afr; 2013 Jul; 24(6):218-23. PubMed ID: 23775037
[TBL] [Abstract][Full Text] [Related]
14. Viral causes of cardiac inflammation.
Bowles NE; Vallejo J
Curr Opin Cardiol; 2003 May; 18(3):182-8. PubMed ID: 12826818
[TBL] [Abstract][Full Text] [Related]
15. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
[TBL] [Abstract][Full Text] [Related]
16. Virus-Host Interactions of Enteroviruses and Parvovirus B19 in Myocarditis.
Ho HT; Peischard S; Strutz-Seebohm N; Seebohm G
Cell Physiol Biochem; 2021 Nov; 55(6):679-703. PubMed ID: 34791861
[TBL] [Abstract][Full Text] [Related]
17. Advanced detection strategies for cardiotropic virus infection in a cohort study of heart failure patients.
Hanson PJ; Liu-Fei F; Minato TA; Hossain AR; Rai H; Chen VA; Ng C; Ask K; Hirota JA; McManus BM
Lab Invest; 2022 Jan; 102(1):14-24. PubMed ID: 34608239
[TBL] [Abstract][Full Text] [Related]
18. Retrospective evaluation of antibody index of human parvovirus B19 as a prognostic factor in patients with dilated and ischemic cardiomyopathy.
Zedtwitz-Liebenstein K; Robak O; Burgmann H; Frass M
J Med Virol; 2013 Jun; 85(6):1111-4. PubMed ID: 23588739
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load.
Dennert R; Velthuis S; Schalla S; Eurlings L; van Suylen RJ; van Paassen P; Tervaert JW; Wolffs P; Goossens VJ; Bruggeman C; Waltenberger J; Crijns HJ; Heymans S
Antivir Ther; 2010; 15(2):193-201. PubMed ID: 20386074
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy.
Dennert R; Velthuis S; Westermann D; Donker D; Schalla S; van Suylen RJ; Heymans S
Antivir Ther; 2010; 15(4):681-5. PubMed ID: 20587861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
